Ocular Myasthenia Gravis
📧 Sign up to get email alerts when something new happens for Ocular Myasthenia Gravis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-03-17Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Rozanolixizumab in Adult Participants With Ocular Myasthenia Gravis [Phase 3]
A Phase 3 clinical trial evaluating the efficacy and safety of Rozanolixizumab for ocular myasthenia gravis in adults is listed as NOT_YET_R…
-
CLINICAL_TRIALS trial_result · 2026-01-21Clinical Trial Update: Immediate Corticosteroid Therapy and Rituximab to Prevent Generalization in Ocular Myasthenia: a PROBE Multicenter Open-label Randomized Controlled Trial. [Phase 3]
Phase 3 PROBE multicenter open-label randomized trial evaluating immediate corticosteroid therapy combined with rituximab to prevent general…
-
CLINICAL_TRIALS trial_result · 2021-09-16Clinical Trial Update: Efficacy of Apraclonidine Eye Drops in the Treatment of Ptosis Secondary to Myasthenia Gravis [Phase 2]
Phase 2 clinical trial evaluating the efficacy of apraclonidine eye drops for ptosis in myasthenia gravis, completed.
-
CLINICAL_TRIALS trial_result · 2015-11-02Clinical Trial Update: Efficacy of Prednisone In the Treatment of Ocular Myasthenia [Phase 3]
A Phase 3 trial evaluating prednisone for ocular myasthenia gravis was terminated, with results posted in 2015.